J Virues-Ortega

Summary

Affiliation: Instituto de Salud Carlos III
Country: Spain

Publications

  1. ncbi Cross-cultural evaluation of the modified Parkinson Psychosis Rating Scale across disease stages
    Javier Virues-Ortega
    Consortium for Biomedical Research in Neurodegenerative Diseases, Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas, Madrid, Spain
    Mov Disord 25:1391-8. 2010
  2. ncbi Prevalence of dementia and major dementia subtypes in Spanish populations: a reanalysis of dementia prevalence surveys, 1990-2008
    Jesus de Pedro-Cuesta
    National Centre for Epidemiology, CIBERNED and Alzheimer Disease Research Unit, Carlos III Institute of Public Health, Madrid, Spain
    BMC Neurol 9:55. 2009
  3. ncbi [Cross-cultural validation of Antonovsky's Sense of Coherence Scale (OLQ-13) in Spanish elders aged 70 years or more]
    Javier Virues-Ortega
    Centro Nacional de Epidemiologia, Instituto de Salud Carlos III, Madrid, Espana
    Med Clin (Barc) 128:486-92. 2007
  4. ncbi Cross-cultural validation of the Scales for Outcomes in Parkinson's Disease-Psychosocial questionnaire (SCOPA-PS) in four Latin American countries
    Javier Virues-Ortega
    National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain
    Value Health 12:385-91. 2009
  5. ncbi Prevalence and European comparison of dementia in a ?75-year-old composite population in Spain
    J Virues-Ortega
    National Centre for Epidemiology, Research Network in Nerodegenerative Disease, Carlos III Institute of Health, Madrid, Spain
    Acta Neurol Scand 123:316-24. 2011
  6. ncbi ICF-based disability survey in a rural population of adults and older adults living in Cinco Villas, Northeastern Spain: design, methods and population characteristics
    Jesus de Pedro-Cuesta
    Department of Applied Epidemiology, National Centre for Epidemiology, Carlos III Institute of Health, ES 28029 Madrid, Spain
    Neuroepidemiology 35:72-82. 2010
  7. ncbi Psychophysiological effects of human-animal interaction: theoretical issues and long-term interaction effects
    Javier Virues-Ortega
    Instituto de Salud Carlos III, Centro Nacional de Epidemiologia, Madrid, Spain
    J Nerv Ment Dis 194:52-7. 2006
  8. ncbi Applied behavior analytic intervention for autism in early childhood: meta-analysis, meta-regression and dose-response meta-analysis of multiple outcomes
    Javier Virues-Ortega
    Centro Nacional de Epidemiologia, Instituto de Salud Carlos III, CIBERNED, Madrid, Spain
    Clin Psychol Rev 30:387-99. 2010

Collaborators

Detail Information

Publications8

  1. ncbi Cross-cultural evaluation of the modified Parkinson Psychosis Rating Scale across disease stages
    Javier Virues-Ortega
    Consortium for Biomedical Research in Neurodegenerative Diseases, Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas, Madrid, Spain
    Mov Disord 25:1391-8. 2010
    ..The results show that some psychometric properties of the mPPRS are satisfactory albeit there is room for the improvement of scale's content validity and internal consistency. (c) 2010 Movement Disorder Society...
  2. ncbi Prevalence of dementia and major dementia subtypes in Spanish populations: a reanalysis of dementia prevalence surveys, 1990-2008
    Jesus de Pedro-Cuesta
    National Centre for Epidemiology, CIBERNED and Alzheimer Disease Research Unit, Carlos III Institute of Public Health, Madrid, Spain
    BMC Neurol 9:55. 2009
    ..This study describes the prevalence of dementia and major dementia subtypes in Spanish elderly...
  3. ncbi [Cross-cultural validation of Antonovsky's Sense of Coherence Scale (OLQ-13) in Spanish elders aged 70 years or more]
    Javier Virues-Ortega
    Centro Nacional de Epidemiologia, Instituto de Salud Carlos III, Madrid, Espana
    Med Clin (Barc) 128:486-92. 2007
    ..This paper reports on the cross-cultural validation of Antonovsky's Sense of Coherence Scale (OLQ-13) in a sample of Spanish senior citizens...
  4. ncbi Cross-cultural validation of the Scales for Outcomes in Parkinson's Disease-Psychosocial questionnaire (SCOPA-PS) in four Latin American countries
    Javier Virues-Ortega
    National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain
    Value Health 12:385-91. 2009
    ..To conduct a cross-national validation of the Scales for Outcomes in Parkinson's Disease-PsychoSocial questionnaire (SCOPA-PS) in four Latin American Countries...
  5. ncbi Prevalence and European comparison of dementia in a ?75-year-old composite population in Spain
    J Virues-Ortega
    National Centre for Epidemiology, Research Network in Nerodegenerative Disease, Carlos III Institute of Health, Madrid, Spain
    Acta Neurol Scand 123:316-24. 2011
    ..To estimate dementia prevalence in Spain...
  6. ncbi ICF-based disability survey in a rural population of adults and older adults living in Cinco Villas, Northeastern Spain: design, methods and population characteristics
    Jesus de Pedro-Cuesta
    Department of Applied Epidemiology, National Centre for Epidemiology, Carlos III Institute of Health, ES 28029 Madrid, Spain
    Neuroepidemiology 35:72-82. 2010
    ..This study will set the basis for the development of disability-related services for the rural elderly in northeastern Spain...
  7. ncbi Psychophysiological effects of human-animal interaction: theoretical issues and long-term interaction effects
    Javier Virues-Ortega
    Instituto de Salud Carlos III, Centro Nacional de Epidemiologia, Madrid, Spain
    J Nerv Ment Dis 194:52-7. 2006
    ..These mechanisms may partially account for the long-term health outcomes observed in a number of human-animal interaction studies...
  8. ncbi Applied behavior analytic intervention for autism in early childhood: meta-analysis, meta-regression and dose-response meta-analysis of multiple outcomes
    Javier Virues-Ortega
    Centro Nacional de Epidemiologia, Instituto de Salud Carlos III, CIBERNED, Madrid, Spain
    Clin Psychol Rev 30:387-99. 2010
    ..Dose-dependant effect sizes were apparent by levels of total treatment hours for language and adaptation composite scores. Methodological issues relating ABA clinical trials for autism are discussed...